How the melanoma mutational landscape can be used to help research, patients, doctors and society

In my last blog post, I tried to convince you why heterogeneity (diversity) is important to consider in the case of melanoma. As individuals, we are all different. Therefore, as patients our disease progression as well as our response to treatment will also be different. An example of howRead More